Methods of treating cancer using IL-21 and monoclonal antibody therapy

Details for Australian Patent Application No. 2005245031 (hide)

Owner ZymoGenetics, Inc.

Inventors Foster, Donald C.; Kindsvogel, Wayne R.; Johnson, Rebecca A.; Clegg, Christopher H.; Holly, Richard D.; Heipel, Mark D.; Hughes, Steven D.; Sivakumar, Pallavur V.

Agent Spruson & Ferguson

Pub. Number AU-B-2005245031

PCT Pub. Number WO2005/113001

Priority 60/572,973 20.05.04 US; 60/680,447 12.05.05 US; 60/635,380 10.12.04 US; 60/671,281 14.04.05 US

Filing date 20 May 2005

Wipo publication date 1 December 2005

Acceptance publication date 18 August 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/113001 Priority application(s): WO2005/113001

18 August 2011 Application Accepted

  Published as AU-B-2005245031

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005245038-Nozzle protector cap

2005245030-Adapter for blender pitcher